{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:31:57Z","timestamp":1793723517083,"version":"4.6.1"},"reference-count":101,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2022,2,1]]},"abstract":"<jats:p>Hypertension is a major risk factor for the pathogenesis of vascular dementia and Alzheimer\u2019s disease. Chronic activation of the renin-angiotensin system (RAS) contributes substantially to neuroinflammation. We propose that neuroinflammation arising from chronic RAS activation can initiate and potentiate the onset of hypertension and related dementia. Neuroinflammation induced by chronic activation of the RAS plays a key role in the pathogenesis of dementia. Increased levels of pro-inflammatory cytokines tumor necrosis factor (TNF)-\u03b1, interleukin (IL)-1\u03b2, and transforming growth factor (TGF)-\u03b2 have been reported in brain tissue of vascular dementia patients and animal models of vascular dementia induced by either angiotensin II infusion or transverse aortic coarctation. It is proposed that neuronal cell death and synaptic dysfunction induced by neuroinflammation lead to cognitive impairment in dementia. The neuroprotective RAS pathway, regulated by angiotensin-converting enzyme 2 (ACE2) which converts angiotensin II into angiotensin-(1\u20137), can attenuate hypertension and dementia. Furthermore, the use of anti-hypertensive medications in preventing dementia or cognitive decline in hypertensive patients and animal models of dementia have mostly been beneficial. Current evidence suggests a strong link between RAS induced neuroinflammation and the onset of hypertension and dementia, which warrants further investigation. Strategies to counteract an overactive RAS and enhance the neuroprotective arm of the RAS may help prevent or improve cognitive impairment associated with hypertension.<\/jats:p>","DOI":"10.3233\/jad-215231","type":"journal-article","created":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T14:18:15Z","timestamp":1638886695000},"page":"943-955","source":"Crossref","is-referenced-by-count":35,"title":["Chronic Renin-Angiotensin System Activation Induced Neuroinflammation: Common Mechanisms Underlying Hypertension and Dementia?"],"prefix":"10.1177","volume":"85","author":[{"given":"Shirley","family":"Tran","sequence":"first","affiliation":[{"name":"School of Biomedical Sciences, University of Queensland, St. Lucia, QLD, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjaya","family":"Kuruppu","sequence":"additional","affiliation":[{"name":"School of Biomedical Sciences, University of Queensland, St. Lucia, QLD, Australia"},{"name":"Department of Biochemistry & Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niwanthi W.","family":"Rajapakse","sequence":"additional","affiliation":[{"name":"School of Biomedical Sciences, University of Queensland, St. Lucia, QLD, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-215231_ref1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0140-6736(05)17741-1","article-title":"Global burden of hypertension: Analysis of worldwide data","volume":"365","author":"Kearney","year":"2005","journal-title":"Lancet"},{"key":"10.3233\/JAD-215231_ref2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4103\/2249-4863.154630","article-title":"Resistant hypertension: An approach tomanagement in primary care","volume":"4","author":"Yaxley","year":"2015","journal-title":"J Family Med Prim Care"},{"key":"10.3233\/JAD-215231_ref3","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/hr.2013.51","article-title":"Renin\u2013angiotensin\u2013aldosterone system has a pivotal role in cognitive impairment","volume":"36","author":"Yagi","year":"2013","journal-title":"Hypertens Res"},{"key":"10.3233\/JAD-215231_ref4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fcvm.2020.00005","article-title":"Hypertension and the risk of dementia","volume":"7","author":"Sierra","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"10.3233\/JAD-215231_ref5","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3233\/JAD-190474","article-title":"Midlifehypertension and Alzheimer\u2019s disease: A systematic review andmeta-analysis","volume":"71","author":"Lennon","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-215231_ref6","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1161\/HYPERTENSIONAHA.114.04257","article-title":"Hypertension and Alzheimer disease: Another brick inthe wall of awareness","volume":"65","author":"Thorin","year":"2015","journal-title":"Hypertension"},{"key":"10.3233\/JAD-215231_ref7","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/YCO.0000000000000684","article-title":"Hypertension and Alzheimer\u2019sdisease: Is the picture any clearer?","volume":"34","author":"Lennon","year":"2021","journal-title":"Curr Opin Psychiatry"},{"key":"10.3233\/JAD-215231_ref8","first-page":"327","article-title":"Vascular dementia: Pharmacological treatmentapproaches and perspectives","volume":"2","author":"Baskys","year":"2007","journal-title":"Clin Interv Aging"},{"key":"10.3233\/JAD-215231_ref9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2318-14-19","article-title":"The treatment of hypertensionin people with dementia: A systematic review of observationalstudies","volume":"14","author":"Welsh","year":"2014","journal-title":"BMC Geriatr"},{"key":"10.3233\/JAD-215231_ref10","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/alz.12068","article-title":"2020 Alzheimer\u2019s disease facts and figures","volume":"16","author":"Alzheimer\u2019s","year":"2020","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-215231_ref11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/1756285612461679","article-title":"Current and future treatments for Alzheimer\u2019s disease","volume":"6","author":"Yiannopoulou","year":"2013","journal-title":"Ther Adv Neurol Disord"},{"key":"10.3233\/JAD-215231_ref12","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.neuroscience.2010.09.029","article-title":"Angiotensin II induced cerebral microvascular inflammation and increased blood\u2013brain barrier permeability via oxidative stress","volume":"171","author":"Zhang","year":"2010","journal-title":"Neuroscience"},{"key":"10.3233\/JAD-215231_ref13","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12974-018-1090-z","article-title":"Differential effect of angiotensin II and blood pressure on hippocampal inflammation in mice","volume":"15","author":"Iulita","year":"2018","journal-title":"J Neuroinflammation"},{"key":"10.3233\/JAD-215231_ref14","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41440-018-0090-9","article-title":"Hypertension-induced cognitive impairment: Insights fromprolonged angiotensin II infusion in mice","volume":"41","author":"Foulquier","year":"2018","journal-title":"Hypertens Res"},{"key":"10.3233\/JAD-215231_ref15","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/jnc.13905","article-title":"Structural and functional brain alterations in a murine model of Angiotensin II-induced hypertension","volume":"140","author":"Meissner","year":"2017","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-215231_ref16","doi-asserted-by":"crossref","first-page":"761","DOI":"10.7326\/0003-4819-139-9-200311040-00011","article-title":"Pathogenesis of hypertension","volume":"139","author":"Oparil","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.3233\/JAD-215231_ref17","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41569-019-0244-8","article-title":"Counter-regulatory renin-angiotensin system in cardiovascular disease","volume":"17","author":"Paz Ocaranza","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.3233\/JAD-215231_ref18","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.3233\/JAD-171119","article-title":"The coming of age of the angiotensin hypothesis inAlzheimer\u2019s disease: Progress toward disease prevention andtreatment?","volume":"62","author":"Kehoe","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-215231_ref19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/HYPERTENSIONAHA.117.08550","article-title":"How is the brain renin-angiotensin system regulated?","volume":"70","author":"Nakagawa","year":"2017","journal-title":"Hypertension"},{"key":"10.3233\/JAD-215231_ref20","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s11906-010-0105-7","article-title":"Angiotensin-converting enzyme 2: Centralregulator for cardiovascular function","volume":"12","author":"Xia","year":"2010","journal-title":"Curr Hypertens Rep"},{"key":"10.3233\/JAD-215231_ref21","doi-asserted-by":"crossref","first-page":"33238","DOI":"10.1074\/jbc.M002615200","article-title":"A human homolog of angiotensin-converting enzyme: Cloning andfunctional expression as a captopril-insensitive carboxypeptidase","volume":"275","author":"Tipnis","year":"2000","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-215231_ref22","doi-asserted-by":"crossref","first-page":"4703","DOI":"10.1210\/en.2004-0443","article-title":"The novel angiotensin-converting enzyme (ACE) homolog, ACE2, is selectively expressed by adult Leydig cells of the testis","volume":"145","author":"Douglas","year":"2004","journal-title":"Endocrinology"},{"key":"10.3233\/JAD-215231_ref23","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1186\/s13054-020-03120-0","article-title":"Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19","volume":"24","author":"Ni","year":"2020","journal-title":"Crit Care"},{"key":"10.3233\/JAD-215231_ref24","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.2353\/ajpath.2007.061088","article-title":"Pathology and pathogenesis of severe acute respiratory syndrome","volume":"170","author":"Gu","year":"2007","journal-title":"Am J Pathol"},{"key":"10.3233\/JAD-215231_ref25","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/s41440-020-0476-3","article-title":"Downregulation ofACE2 induces overstimulation of the renin\u2013angiotensin system inCOVID-19: Should we block the renin\u2013angiotensin system?","volume":"43","author":"Silhol","year":"2020","journal-title":"Hypertens Res"},{"key":"10.3233\/JAD-215231_ref26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2990.2007.00885.x","article-title":"Angiotensin-converting enzyme (ACE) levels and activity in Alzheimer\u2019s disease, and relationship of perivascular ACE-1 to cerebral amyloid angiopathy","volume":"34","author":"Miners","year":"2008","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.3233\/JAD-215231_ref27","first-page":"163","article-title":"Angiotensin-converting enzyme levels andactivity in Alzheimer\u2019s disease: Differences in brain and CSF ACEand association with ACE1 genotypes","volume":"1","author":"Miners","year":"2009","journal-title":"Am J Transl Res"},{"key":"10.3233\/JAD-215231_ref28","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1111\/j.1471-4159.1982.tb07930.x","article-title":"Angiotensinconverting enzyme in Alzheimer\u2019s disease: Increased activity incaudate nucleus and cortical areas","volume":"38","author":"Arregui","year":"1982","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-215231_ref29","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0014-2999(91)90584-D","article-title":"Angiotensin converting enzyme density is increased in temporal cortex from patients with Alzheimer\u2019s disease","volume":"200","author":"Barnes","year":"1991","journal-title":"Eur J Pharmacol"},{"key":"10.3233\/JAD-215231_ref30","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13195-016-0217-7","article-title":"Angiotensin-converting enzyme 2 is reduced in Alzheimer\u2019s disease inassociation with increasing amyloid-\u03b2 and tau pathology","volume":"8","author":"Kehoe","year":"2016","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-215231_ref31","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1161\/STROKEAHA.116.012658","article-title":"Blood pressure and risk of vasculardementia: Evidence from a primary care registry and a cohort studyof transient ischemic attack and stroke","volume":"47","author":"Emdin","year":"2016","journal-title":"Stroke"},{"key":"10.3233\/JAD-215231_ref32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.31887\/DCNS.2007.9.1\/ctzourio","article-title":"Hypertension, cognitive decline, and dementia: Anepidemiological perspective","volume":"9","author":"Tzourio","year":"2007","journal-title":"Dialogues Clin Neurosci"},{"key":"10.3233\/JAD-215231_ref33","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jneuroim.2018.04.004","article-title":"The involvement of neuroinflammation and necroptosis in the hippocampus during vascular dementia","volume":"320","author":"Belkhelfa","year":"2018","journal-title":"J Neuroimmunol"},{"key":"10.3233\/JAD-215231_ref34","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1001\/archneur.61.5.668","article-title":"Inflammatory proteins in plasma and the risk of dementia: The Rotterdam Study","volume":"61","author":"Engelhart","year":"2004","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-215231_ref35","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1600-0404.2004.00286.x","article-title":"Elevated interleukin-6 levels in cerebrospinal fluid of vascular dementia patients","volume":"110","author":"Wada-Isoe","year":"2004","journal-title":"Acta Neurol Scand"},{"key":"10.3233\/JAD-215231_ref36","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/cvr\/cvn119","article-title":"Cross-talk between cytokines and renin-angiotensin in hypothalamic paraventricular nucleus in heart failure: Role of nuclearfactor-kappaB","volume":"79","author":"Kang","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.3233\/JAD-215231_ref37","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0165-3806(88)90045-4","article-title":"Immunohistochemical studies on the proliferation of reactive astrocytes and the expression of cytoskeletal proteins following brain injury in rats","volume":"466","author":"Takamiya","year":"1988","journal-title":"Brain Res"},{"key":"10.3233\/JAD-215231_ref38","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0306-4522(00)00297-9","article-title":"The hippocampusin spontaneously hypertensive rats: A quantitative microanatomicalstudy","volume":"100","author":"Sabbatini","year":"2000","journal-title":"Neuroscience"},{"key":"10.3233\/JAD-215231_ref39","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1212\/WNL.58.8.1175","article-title":"The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function","volume":"58","author":"Posner","year":"2002","journal-title":"Neurology"},{"key":"10.3233\/JAD-215231_ref40","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1161\/HYPERTENSIONAHA.110.150409","article-title":"Brain microglial cytokines in neurogenic hypertension","volume":"56","author":"Shi","year":"2010","journal-title":"Hypertension"},{"key":"10.3233\/JAD-215231_ref41","doi-asserted-by":"crossref","first-page":"205.e219","DOI":"10.1016\/j.neurobiolaging.2010.08.013","article-title":"Role of neuroinflammation in hypertension-induced brain amyloid pathology","volume":"33","author":"Carnevale","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-215231_ref42","first-page":"1729","article-title":"Transverse aortic constriction in mice","author":"deAlmeida","year":"2010","journal-title":"J Vis Exp"},{"key":"10.3233\/JAD-215231_ref43","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3233\/JAD-181000","article-title":"Chronic angiotensin 1-7 infusion prevents angiotensin-II-induced cognitive dysfunction and skeletal muscle injury in a mouse model of Alzheimer\u2019s disease","volume":"69","author":"Cao","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-215231_ref44","doi-asserted-by":"crossref","first-page":"30049","DOI":"10.18632\/oncotarget.9174","article-title":"Crosstalk between insulin-like growthfactor-1 and angiotensin-II in dopaminergic neurons and glial cells:Role in neuroinflammation and aging","volume":"7","author":"Rodriguez-Perez","year":"2016","journal-title":"Oncotarget"},{"key":"10.3233\/JAD-215231_ref45","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.aag2590","article-title":"How neuroinflammation contributes to neurodegeneration","volume":"353","author":"Ransohoff","year":"2016","journal-title":"Science"},{"key":"10.3233\/JAD-215231_ref46","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.3390\/ijms19103082","article-title":"Neuronal cell death mechanisms in major neurodegenerative diseases","volume":"19","author":"Chi","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.3233\/JAD-215231_ref47","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s12035-014-8868-5","article-title":"Activated microglia-induced deficitsin excitatory synapses through IL-1\u03b2: Implications forcognitive impairment in sepsis","volume":"52","author":"Moraes","year":"2015","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JAD-215231_ref48","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s11481-012-9342-7","article-title":"Synapse loss induced byinterleukin-1\u03b2 requires pre- and post-synaptic mechanisms","volume":"7","author":"Mishra","year":"2012","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.3233\/JAD-215231_ref49","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12974-019-1490-8","article-title":"Lipopolysaccharide-induced neuroinflammation induces presynaptic disruption through a direct action on brain tissue involving microglia-derived interleukin 1 beta","volume":"16","author":"Sheppard","year":"2019","journal-title":"J Neuroinflammation"},{"key":"10.3233\/JAD-215231_ref50","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.3892\/mmr.2016.4853","article-title":"Age-related changes in hypertensive brain damage in the hippocampi of spontaneously hypertensive rats","volume":"13","author":"Li","year":"2016","journal-title":"Mol Med Rep"},{"key":"10.3233\/JAD-215231_ref51","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.brainres.2019.05.002","article-title":"Angiotensin II triggers autophagy and apoptosis in PC12 cell line: An in vitro Alzheimer\u2019s disease model","volume":"1718","author":"Tian","year":"2019","journal-title":"Brain Res"},{"key":"10.3233\/JAD-215231_ref52","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/sctm.16-0382","article-title":"Angiotensin II causesapoptosis of adult hippocampal neural stem cells and memoryimpairment through the action on AMPK-PGC1\u03b1 signaling inheart failure","volume":"6","author":"Kim","year":"2017","journal-title":"Stem Cells Transl Med"},{"key":"10.3233\/JAD-215231_ref53","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0149-7634(02)00019-2","article-title":"Neural plasticity and the brain renin\u2013angiotensin system","volume":"26","author":"Wright","year":"2002","journal-title":"Neurosci Biobehav Rev"},{"key":"10.3233\/JAD-215231_ref54","doi-asserted-by":"crossref","first-page":"778","DOI":"10.3389\/fphar.2019.00778","article-title":"Targeting synaptic plasticity in experimental models of Alzheimer\u2019s disease","volume":"10","author":"Mango","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.3233\/JAD-215231_ref55","doi-asserted-by":"crossref","first-page":"e76860","DOI":"10.1371\/journal.pone.0076860","article-title":"Long-term potentiation promotes proliferation\/survival and neuronal differentiation of neural stem\/progenitor cells","volume":"8","author":"Cho","year":"2013","journal-title":"PLoS One"},{"key":"10.3233\/JAD-215231_ref56","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fnana.2018.00104","article-title":"Neural progenitor cell terminology","volume":"12","author":"Mart\u00ednez-Cerde\u00f1o","year":"2018","journal-title":"Front Neuroanat"},{"key":"10.3233\/JAD-215231_ref57","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.physbeh.2012.10.005","article-title":"Chronic perfusion of angiotensin II causes cognitive dysfunctions and anxiety in mice","volume":"109","author":"Duchemin","year":"2013","journal-title":"Physiol Behav"},{"key":"10.3233\/JAD-215231_ref58","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.yhbeh.2006.03.016","article-title":"Angiotensin II disrupts inhibitory avoidance memory retrieval","volume":"50","author":"Bonini","year":"2006","journal-title":"Horm Behav"},{"key":"10.3233\/JAD-215231_ref59","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1038\/jcbfm.2013.143","article-title":"Age-related autoregulatory dysfunction and cerebromicrovascular injury in mice with angiotensin II-induced hypertension","volume":"33","author":"Toth","year":"2013","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.3233\/JAD-215231_ref60","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1152\/ajpheart.00288.2013","article-title":"Synergistic effects of hypertensionand aging on cognitive function and hippocampal expression of genesinvolved in \u03b2-amyloid generation and Alzheimer\u2019s disease. H1120-H","volume":"305","author":"Csiszar","year":"2013","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.3233\/JAD-215231_ref61","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pnpbp.2017.03.010","article-title":"Minocyclinereduces inflammatory parameters in the brain structures and serumand reverses memory impairment caused by the administration ofamyloid \u03b2 (1-42) in mice","volume":"77","author":"Garcez","year":"2017","journal-title":"Prog NeuropsychopharmacolBiol Psychiatry"},{"key":"10.3233\/JAD-215231_ref62","doi-asserted-by":"crossref","first-page":"P721","DOI":"10.1016\/j.jalz.2013.05.1443","article-title":"P4\u2013054: Direct angiotensin II type 2 receptor stimulation by compound 21 prevents vascular dementia: Involvement of NMDA receptor activation","volume":"9","author":"Mogi","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-215231_ref63","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jash.2015.01.010","article-title":"Direct angiotensin II type 2 receptor stimulation by compound 21 prevents vascular dementia","volume":"9","author":"Iwanami","year":"2015","journal-title":"J Am Soc Hypertens"},{"key":"10.3233\/JAD-215231_ref64","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/cvr\/cvr242","article-title":"ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension","volume":"92","author":"Sriramula","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.3233\/JAD-215231_ref65","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00401-019-02098-6","article-title":"ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer\u2019s disease","volume":"139","author":"Evans","year":"2020","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-215231_ref66","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12974-016-0489-7","article-title":"Angiotensin-converting enzyme 2 activator diminazene aceturateprevents lipopolysaccharide-induced inflammation by inhibiting MAPKand NF-\u03baB pathways in human retinal pigment epithelium","volume":"13","author":"Tao","year":"2016","journal-title":"J Neuroinflammation"},{"key":"10.3233\/JAD-215231_ref67","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/MNH.0000000000000254","article-title":"Angiotensin convertingenzyme 2 and diminazene: Role in cardiovascular and blood pressureregulation","volume":"25","author":"Velkoska","year":"2016","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.3233\/JAD-215231_ref68","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.brainres.2014.05.019","article-title":"Angiotensin-(1-7) improves cognitive function in rats with chronic cerebral hypoperfusion","volume":"1573","author":"Xie","year":"2014","journal-title":"Brain Res"},{"key":"10.3233\/JAD-215231_ref69","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3233\/JAD-150642","article-title":"Intracerebroventricular infusion of angiotensin-(1\u20137) ameliorates cognitive impairment and memory dysfunction in a mouse model of Alzheimer\u2019s disease","volume":"53","author":"Uekawa","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-215231_ref70","first-page":"646","article-title":"Effects of angiotensin-(1-7) on hippocampal expressions of GFAP and GDNF and cognitive function in rats with diabetes mellitus","volume":"35","author":"Zhang","year":"2015","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"10.3233\/JAD-215231_ref71","doi-asserted-by":"crossref","first-page":"645","DOI":"10.18632\/aging.101419","article-title":"AVE0991, a nonpeptide analogue of Ang-(1-7), attenuates aging-related neuroinflammation","volume":"10","author":"Jiang","year":"2018","journal-title":"Aging"},{"key":"10.3233\/JAD-215231_ref72","doi-asserted-by":"crossref","first-page":"7398","DOI":"10.1158\/1078-0432.CCR-09-1957","article-title":"Phase I and pharmacokinetic study of angiotensin-(1-7), an endogenous antiangiogenic hormone","volume":"15","author":"Petty","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.3233\/JAD-215231_ref73","doi-asserted-by":"crossref","first-page":"876","DOI":"10.3390\/ijms19030876","article-title":"Within the brain: The renin angiotensin system","volume":"19","author":"Jackson","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.3233\/JAD-215231_ref74","first-page":"399s","article-title":"Impermeability of the blood-cerebrospinal fluid barrier for angiotensin II in rats","volume":"3","author":"Schelling","year":"1976","journal-title":"Clin Sci Mol Med Suppl"},{"key":"10.3233\/JAD-215231_ref75","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1161\/HYPERTENSIONAHA.109.138420","article-title":"Targeting the degradation of angiotensin II withrecombinant angiotensin-converting enzyme 2: Prevention ofangiotensin II-dependent hypertension","volume":"55","author":"Wysocki","year":"2010","journal-title":"Hypertension"},{"key":"10.3233\/JAD-215231_ref76","doi-asserted-by":"crossref","first-page":"307315","DOI":"10.1155\/2012\/307315","article-title":"Angiotensin-converting enzyme 2: Thefirst decade","volume":"2012","author":"Clarke","year":"2012","journal-title":"Int J Hypertens"},{"key":"10.3233\/JAD-215231_ref77","doi-asserted-by":"crossref","first-page":"b5465","DOI":"10.1136\/bmj.b5465","article-title":"Use of angiotensin receptor blockers and risk of dementiain a predominantly male population: Prospective cohort analysis","volume":"340","author":"Li","year":"2010","journal-title":"BMJ"},{"key":"10.3233\/JAD-215231_ref78","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3233\/JAD-2011-110347","article-title":"Associations of anti-hypertensive treatments with Alzheimer\u2019s disease, vascular dementia, and other dementias","volume":"26","author":"Davies","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-215231_ref79","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0197-4580(00)00241-4","article-title":"Antihypertensive drugs and incidence of dementia: TheRotterdam Study","volume":"22","author":"in\u2019t Veld","year":"2001","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-215231_ref80","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1001\/archinte.162.18.2046","article-title":"The prevention of dementia with antihypertensive treatment: Newevidence from the Systolic Hypertension in Europe (Syst-Eur) study","volume":"162","author":"Forette","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.3233\/JAD-215231_ref81","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1001\/archinternmed.2009.175","article-title":"Angiotensin-converting enzyme inhibitors and cognitive decline inolder adults with hypertension: Results from the CardiovascularHealth Study","volume":"169","author":"Sink","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.3233\/JAD-215231_ref82","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1001\/archneur.63.5.noc60013","article-title":"Antihypertensive medication use and incident Alzheimer disease: TheCache County Study","volume":"63","author":"Khachaturian","year":"2006","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-215231_ref83","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/bmj.324.7339.699","article-title":"Use of ramipril in preventing stroke:Double blind randomised trial","volume":"324","author":"Bosch","year":"2002","journal-title":"BMJ"},{"key":"10.3233\/JAD-215231_ref84","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archinte.163.9.1069","article-title":"Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease","volume":"163","author":"Tzourio","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.3233\/JAD-215231_ref85","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3390\/ph14020166","article-title":"Losartan improves memory, neurogenesis and cell motility in transgenic Alzheimer\u2019s mice","volume":"14","author":"Drews","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.3233\/JAD-215231_ref86","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.nbd.2014.04.018","article-title":"Angiotensin II type1 receptor blocker losartan prevents and rescues cerebrovascular,neuropathological and cognitive deficits in an Alzheimer\u2019s diseasemodel","volume":"68","author":"Ongali","year":"2014","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-215231_ref87","first-page":"CD004034","article-title":"Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia","volume":"2009","author":"McGuinness","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.3233\/JAD-215231_ref88","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1447-0594.2011.00746.x","article-title":"Effects of telmisartan on cognition and regional cerebral blood flow in hypertensive patients with Alzheimer\u2019s disease","volume":"12","author":"Kume","year":"2012","journal-title":"Geriatr Gerontol Int"},{"key":"10.3233\/JAD-215231_ref89","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/00004872-200305000-00011","article-title":"The Study on Cognition andPrognosis in the Elderly (SCOPE): Principal results of a randomizeddouble-blind intervention trial","volume":"21","author":"Lithell","year":"2003","journal-title":"J Hypertens"},{"key":"10.3233\/JAD-215231_ref90","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.brainres.2010.07.006","article-title":"Effect of a centrally active angiotensin-converting enzyme inhibitor, perindopril, on cognitive performance in a mouse model of Alzheimer\u2019s disease","volume":"1352","author":"Yamada","year":"2010","journal-title":"Brain Res"},{"key":"10.3233\/JAD-215231_ref91","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1096\/fj.11-182873","article-title":"Perindopril, a centrally active angiotensin-converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer\u2019s disease","volume":"25","author":"Dong","year":"2011","journal-title":"FASEB J"},{"key":"10.3233\/JAD-215231_ref92","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/rej.2009.0944","article-title":"Protective effects of intranasal losartan in the APP\/PS1 transgenic mouse model of Alzheimer disease","volume":"13","author":"Danielyan","year":"2010","journal-title":"Rejuvenation Res"},{"key":"10.3233\/JAD-215231_ref93","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1172\/JCI31547","article-title":"Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease","volume":"117","author":"Wang","year":"2007","journal-title":"J Clin Invest"},{"key":"10.3233\/JAD-215231_ref94","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1161\/HYPERTENSIONAHA.109.136879","article-title":"Cognitive deficit in amyloid-\u03b2 injectedmice was improved by pretreatment with a low dose of telmisartanpartly because of peroxisome proliferator-activatedreceptor-\u03b3 activation","volume":"54","author":"Tsukuda","year":"2009","journal-title":"Hypertension"},{"key":"10.3233\/JAD-215231_ref95","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.pbb.2014.03.009","article-title":"Non-hypotensive dose of telmisartan and nimodipine produced synergistic neuroprotective effect in cerebral ischemic model by attenuating brain cytokine levels","volume":"122","author":"Justin","year":"2014","journal-title":"Pharmacol Biochem Behav"},{"key":"10.3233\/JAD-215231_ref96","doi-asserted-by":"crossref","first-page":"e0227618","DOI":"10.1371\/journal.pone.0227618","article-title":"Alterations of aqueous humor A\u03b2 levels in A\u03b2-infused and transgenic mouse models of Alzheimer disease","volume":"15","author":"Kwak","year":"2020","journal-title":"PLoS One"},{"key":"10.3233\/JAD-215231_ref97","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.nlm.2006.08.010","article-title":"Effect of chronic angiotensin converting enzyme inhibition on spatial memory and anxiety-like behaviours in rats","volume":"87","author":"Jenkins","year":"2007","journal-title":"Neurobiol Learn Mem"},{"key":"10.3233\/JAD-215231_ref98","doi-asserted-by":"crossref","first-page":"16917","DOI":"10.3390\/ijms140816917","article-title":"ACE inhibition with captopril retards the development of signs of neurodegeneration in an animal model of Alzheimer\u2019s disease","volume":"14","author":"AbdAlla","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.3233\/JAD-215231_ref99","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0197-4580(00)00096-8","article-title":"Midlife blood pressure and dementia: TheHonolulu-Asia aging study","volume":"21","author":"Launer","year":"2000","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-215231_ref100","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S0024-3205(02)02367-6","article-title":"Relationshipbetween blood pressure and Alzheimer\u2019s disease in Linxian County,China","volume":"72","author":"Wu","year":"2003","journal-title":"Life Sci"},{"key":"10.3233\/JAD-215231_ref101","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000264828","article-title":"Hypertension increases the probability of Alzheimer\u2019s disease and of mild cognitive impairment in an Arab community in northern Israel","volume":"34","author":"Israeli-Korn","year":"2010","journal-title":"Neuroepidemiology"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-215231","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:04:58Z","timestamp":1777370698000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-215231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,1]]},"references-count":101,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jad-215231","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,1]]}}}